Cognitive behaviour therapy for mothers of children with food allergy:a case series by Knibb, Rebecca C.
 Healthcare 2015, 3, 1194-1211; doi:10.3390/healthcare3041194 
 
healthcare 
ISSN 2227-9032 
www.mdpi.com/journal/healthcare 
Article 
Effectiveness of Cognitive Behaviour Therapy for Mothers of 
Children with Food Allergy: A Case Series 
Rebecca C. Knibb 
Department of Psychology, School of Life and Health Sciences, Aston University,  
Birmingham B4 7ET, UK; E-Mail: r.knibb@aston.ac.uk; Tel.: +44-0121-204-3402;  
Fax: +44-0121-204-3696 
Academic Editor: Helen Pattison 
Received: 15 October 2015 / Accepted: 19 November 2015 / Published: 25 November 2015 
 
Abstract: Background: Food allergy affects quality of life in patients and parents and 
mothers report high levels of anxiety and stress. Cognitive Behaviour Therapy (CBT) may 
be helpful in reducing the psychological impact of food allergy. The aim of this study was 
to examine the appropriateness and effectiveness of CBT to improve psychological outcomes 
in parents of children with food allergy. Methods: Five parents (all mothers) from a local 
allergy clinic requested to have CBT; six mothers acted as controls and completed 
questionnaires only. CBT was individual and face-to face and lasted 12 weeks. All participants 
completed measures of anxiety and depression, worry, stress, general mental health, 
generic and food allergy specific quality of life at baseline and at 12 weeks. Results: Anxiety, 
depression and worry in the CBT group significantly reduced and overall mental health and 
QoL significantly improved from baseline to 12 weeks (all p < 0.05) in mothers in the CBT 
group; control group scores remained stable. Conclusions: CBT appears to be appropriate 
and effective in mothers of children with food allergy and a larger randomised control trial 
now needs to be conducted. Ways in which aspects of CBT can be incorporated into 
allergy clinic visits need investigation. 
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1. Introduction 
Food allergy is an immune-mediated adverse reaction to ingestion of food protein, which causes 
unpleasant symptoms including rash, itching, swelling of mouth and lips, vomiting and anaphylaxis 
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which is a systemic reaction which can be life threatening if not promptly treated with adrenaline [1]. 
Prevalence rates are increasing and currently around 5%–8% of children are affected [1,2]. Treatment 
involves avoidance of the implicated foods and emergency treatment of symptoms caused by accidental 
ingestion. Constant vigilance is therefore needed to avoid these symptoms and a number of studies 
have found that food allergy can have a big impact on the quality of life (QoL) of children and adult 
sufferers as well as their immediate family [3]. Food allergy has also been found to be associated with 
higher levels of stress and anxiety in parents, particular mothers, caring for a food allergic child, 
compared to a general healthy population [4,5]. It is thought that the constant vigilance needed to 
check the safety of foods for their child and the anxiety caused by the potential fatal consequences of 
accidental ingestion of an allergen are to blame [4]. 
Qualitative work has supported these findings and also provides further insights into why food 
allergy can cause such distress. Akeson et al. [6] explored the psychosocial impact of living with 
anaphylaxis in seven parents of children with food allergy. Parents had vivid recall of severe reactions 
in their children, which was seen as a traumatic experience and could explain why they developed high 
levels of anxiety levels which persisted long after the incident. Parents also exhibited great anxiety in 
handing responsibility over to their child (such as reading own food labels, doing own cooking) and 
wanted to retain the control of the food allergy themselves. In a study of six mothers of children aged 6 
to twelve years who were at risk of anaphylaxis, a feeling of living with risk was predominant [7]. The 
risks were perceived not just from the allergy, but from the environment and from people around them 
who might not understand food allergy. Mothers also felt that they lived in fear for both the present 
and the future for their child. 
Looking after a child with food allergy therefore has an effect on the mental health status of the 
parent and guidelines on the management of food allergy state that reducing distress in parents is the 
next important step [8]. Information about food allergy and advice from health care practitioners at 
allergy clinics does not seem to help reduce levels of distress [9] and so for some families further 
support is warranted. Group interventions may be helpful; LeBovidge et al. [10] delivered an educational 
workshop to parents and children with food allergy, which resulted in parents reporting an increase in 
perceived competence in coping and reduction in burden of coping with their child’s allergy. The study 
did not use validated measures or a control group and so although results provide some preliminary 
evidence for the efficacy of educational group interventions, further research is needed. Polloni et al. [11] 
assessed reasons for psychological treatment for food allergy in 100 consecutive families attending an 
allergy clinic in Italy. A total of 40% reported emotional and social problems such as anxiety, fear, stress, 
social isolation and poor self-esteem. A further 40% reported difficulties in managing food allergy and 
poor coping strategies for dietary management. Psychological support was provided mostly for children 
and adolescents by a clinical psychologist, although there is a lack of detail provided regarding the 
type of support offered. All patients reported their problems were a bit or much better after receiving 
support and nearly all said their problems were now more bearable. 
For many families then, brief interventions may help them manage food allergy more effectively 
and reduce the stress and worry that can be involved. In some cases though, parents suffer prolonged 
and very high levels of anxiety and worry, particularly if the child has suffered a life threatening 
anaphylactic reaction [6,7]; for these parents more targeted therapy such as individual Cognitive 
Behaviour Therapy (CBT) may be more effective. CBT is an evidence based talking therapy which 
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focuses on present difficulties including symptoms, emotions, behaviour and negative thoughts. Therapy 
involves an assessment of how these factors interact to cause and maintain mental health issues such as 
anxiety and depression and techniques are used to change behaviour or thoughts to help promote better 
mental health. It has been shown to be extremely effective for reducing levels of anxiety (e.g., [12,13]) 
and effective for people suffering from chronic conditions such as asthma and chronic obstructive 
pulmonary disease (e.g., [14,15]). Randomised control trials for CBT for those with asthma has been 
found to increase QoL and reduce anxiety [14,16], reduce depression and asthma-specific fear and 
improve asthma specific QoL [17]. These studies adopted individual face-to-face CBT over eight to ten 
weeks offering support for this method of CBT delivery in allergy related conditions. 
Very few studies have investigated efficacy of CBT for improving psychological outcomes in 
parents. Wong and Poon [18] provided ten weeks of group CBT to 58 Chinese parents of children with 
developmental disabilities and found significant improvements in general health of the parent, parental 
stress and parental quality of life compared to a control group post-treatment. No study to date has 
reported on the appropriateness or effectiveness of individual face-to-face CBT for improving psychosocial 
outcomes in parents of children with food allergy. The presented case series aims to investigate 
whether individual CBT is an appropriate therapy for these parents and whether it could be effective in 
reducing anxiety, depression, worry and stress and improve QoL. 
2. Methods 
2.1. Design 
This study employed a non-randomised case control design and a case series of five parents who 
underwent CBT is presented here. The study was given ethical approval by the Derby Hospitals NHS 
Trust Research Ethics Committee for the East Midlands (reference number: 11/EM/0401). It was also 
registered with the Derbyshire NHS Trust Research and Development Office. All participants were 
recruited from Derby Children’s Hospital and gave written informed consent before taking part in the study. 
2.2. Participants 
Participants (n = 11) were all mothers of children diagnosed with food allergy at a local allergy clinic; 
5 mothers had CBT and 6 mothers were recruited to a control group. 
2.2.1. Inclusion Criteria 
Participants had to have at least one child with a clinical diagnosis of food allergy (diagnosed by 
skin prick tests, blood tests or food challenge by an allergy specialist or paediatrician). Participants 
requesting CBT had to have difficulties that were suitable for treatment with this therapy; this included 
high stress levels, high anxiety, high levels of worry and/or low mood. This was assessed during a 
CBT assessment session and was aided by the scores obtained on the questionnaires, and the 
diagnostic manual DSM-IV-R [19]. Participants also needed to be able to understand written and 
spoken English. 
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2.2.2. Exclusion Criteria 
Exclusion criteria were currently being treated by a psychiatrist or a psychotherapist; taking 
medication for anxiety or depression; currently suffering from a chronic illness that may impact on 
quality of life or mental health; not having a child that suffers from food allergy. 
2.3. Materials 
2.3.1. Demographic and Food Allergy Questionnaire 
A questionnaire to gather demographic information from the parent and food allergy information 
about their child was developed based on that used in previous published studies [5]. Information collected 
included the type of food allergy, symptoms, how the allergy was diagnosed, medication, history of 
anaphylaxis and presence of other atopic conditions such as asthma, hay-fever and eczema. 
2.3.2. Hospital Anxiety and Depression Scale (HADS) 
The HADS [20] is a 14-item self-report measure of anxiety and depression; higher scores indicate 
greater anxiety and depression. It has cut off scores to detect clinical cases of anxiety and depression: 
scores of 0–7 are classified as normal, 8–10 as mild, 11–14 as moderate and 15–21 as severe. The measure 
has excellent internal consistency with Cronbach’s α of 0.93 for anxiety and 0.90 for depression and 
the scale has good construct validity [21]. 
2.3.3. Perceived Stress Scale (PSS-14) 
The PSS-14 [22] is a 14-item self-report measure which asks about thoughts and feelings in the last 
month, with a higher score indicating greater perceived stress. This measure has good internal consistency 
(Cronbach’s α = 0.84) [23]. 
2.3.4. Food Allergy Quality of Life-Parental Burden Scale (FAQL-PB) 
The FAQL-PB scale [24] is a 17-item instrument which asks about the burden of food allergy felt 
by the family; higher scores indicate greater perceived burden. Internal consistency in a U.K. sample [25] 
has been reported as strong (Cronbach’s α = 0.95) and it also demonstrated good convergent and 
construct validity. 
2.3.5. The World Health Organisation QoL Scale (Brief Version) (WHOQOL-BREF) 
The WHOQOL-BREF [26] is a 26 item QoL scale, which measures four major domains: physical, 
psychological, social relationships and environment. A higher score on this scale relates to better 
quality of life. The scale has good reliability across domains (alphas range from 0.68 to 0.82) [26]. 
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2.3.6. Penn State Worry Questionnaire (PSWQ) 
The PSWQ [27] is a 16 item scale to measure worry. Higher scores indicate greater worry, with 
scores over 45 indicating Generalised Anxiety Disorder. The scale has excellent internal consistency 
(Cronbach’s α > 0.7), good test re-test reliability and good validity [27]. 
2.3.7. General Health Questionnaire-12 (GHQ-12) 
The GHQ-12 [28] is a 12 item scale of current mental health. Scores over 11–12 indicate clinical 
caseness. The scale has excellent internal consistency (Cronbach’s α = 0.77–0.93) and good validity [28]. 
2.3.8. Problems and Targets 
A problem list and end targets were developed collaboratively with each participant following 
established guidelines [29]. Problem statements were based on areas mothers wanted to address where 
they felt they were not coping well and were causing emotional distress. They were rated on a 9 point 
Likert Scale from 0 to 8 for how much the behaviour interfered with their normal activities (behaviour) 
(0 = does not to 8 = continuously) and for how much the problem upset them (discomfort) (0 = does 
not to 8 = very severely). Targets for each problem statement were developed and similarly rated on a 
9 point scale from 0 to 8 for how often they did the target behaviour (0 = complete success to 8 = have 
not made a start) and how much discomfort the target behaviour caused them (0 = none to 8 = very severe). 
2.4. Procedure 
Parents of children who had been diagnosed with food allergy by a local allergy clinic were given 
information about the study, either in person when they attended the clinic, or by a letter sent to their 
home from the clinic. Parents interested in having CBT were invited to a full assessment session. 
Parents not interested in having CBT sessions but wanted to take part in the study were asked to act as 
controls and complete questionnaires only. 
Participants requesting CBT were seen on an individual basis in one of the counseling rooms at the 
University or in their own homes. In the first session participants completed all questionnaires and a 
cognitive and behavioural functional analysis (which focuses on thoughts, behaviours, emotions and 
physical symptoms) was conducted in order to ensure they met the inclusion/exclusion criteria and to 
facilitate the development of an appropriate and tailored treatment plan for that individual [30]. The 
course of CBT was provided one-to-one, once a week for 12 weeks and each session lasted approximately 
one to one and a half hours. Problems and end targets were set with each individual and an evidence-based 
treatment plan was developed. Problems and targets were rated at regular intervals and all questionnaires 
were completed again at week 12. CBT was provided by a chartered and practitioner psychologist with 
extensive training (to Masters level) in CBT and in depth knowledge of food allergy (RK). 
The control group completed the same questionnaires as the CBT group at baseline (during a  
face-to-face session with the researcher) and at week 12 (via post). No participants withdrew from the 
study, but 2 controls were lost to follow-up. 
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2.5. Data Analysis 
All data was coded and analysed using SPSS version 20. All analyses were two-tailed with alpha set 
at 0.05. Kolmogorov-Smirnov tests were run to assess normality, which revealed most scale scores 
were not normally distributed, due to the low numbers of participants. Non-parametric tests were therefore 
used. Differences between cases and controls were analysed using Mann-Whitney U tests for Independent 
Samples. Changes in scale scores from baseline to end of therapy were analysed by Wilcoxon signed-rank 
tests. Effect sizes were estimated by converting z scores for each test statistic to r values (by dividing 
the z value by the square root of the number of observations); small effect sizes have r values of 0.1 to 0.3, 
medium effect sizes have r values 0.3–0.5, large effects are over 0.5 [31]. 
Participants did not have the same number of problems and targets, so baseline and end of treatment 
mean scores were calculated for each participant; all baseline problem scores were summed for each 
participant and divided by the number of problems set to derive a mean baseline problem score and the 
same was done for end of treatment problem scores. The same was applied to target scores. Differences 
in mean problem and target scores from baseline to end of intervention were analysed using Wilcoxon 
signed-rank tests. Improvement scores for problems and targets were calculated by taking the final 
mean score for success on a problem or target away from the initial mean score; larger scores indicated 
bigger improvements in reducing problems and attaining targets. 
3. Results 
3.1. Demographic and Food Allergy Details of Parents and Children 
Demographic and food allergy details for parents in the CBT and control groups and their children 
can be seen in Table 1. The types of foods and symptoms were broadly similar for children of cases 
and controls. The notable differences were more egg and tree nut allergy, multiple food allergies and 
history of anaphylaxis in children of parents who had CBT, however, numbers were too low to run 
analysis to check for differences. There were no significant differences between the age of parents in 
the CBT group and control group or the age of children in these two groups (all p > 0.05) (Table 1). 
Table 1. Demographic and food allergy details for parents and children in the CBT and 
control group. 
Parent and Child Characteristics CBT Group Control Group 
Parents (n) 5 6 
Sex (n%) female 5 (100.0) 6 (100) 
Ethnic origin (n%) White British 5 (100) 6 (100) 
Age, mean in years (SD) 38.80 (4.38) 33.00 (8.46) 
Food Allergic Child   
Sex (n%) male 3 (60.0) 3 (50.0) 
female 2 (40.0) 3 (50.0) 
Age, mean in years (SD) 6.60 (3.36) 5.00 (3.58) 
Age range in years 2–9 2–12 
Time since diagnosis, mean in years (SD) 5.67 (3.23) 3.87 (2.59) 
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Table 1. Cont. 
Parent and Child Characteristics CBT Group Control Group 
Food Allergy, n (%)   
Peanut 3 (60.0) 4 (66.67) 
Treenuts 3 (60.0) 2 (33.33) 
Egg  5 (100.0) 0 
Milk 3 (60.0) 3 (50.0) 
Fish 0 0 
Soy 0 2 (33.33) 
Tomato 0 1 (16.67) 
Number of Food Allergies, n (%)   
1 food 1 (20.0) 2 (33.33) 
2 foods 1 (20.0) 3 (50.0) 
3+ foods 3 (60.0) 1 (16.67) 
Type of Symptoms, n (%)   
Respiratory 4 (80.0) 4 (66.67) 
Swelling of face, lips, tongue, eyes 2 (40.0) 4 (66.67) 
Gastrointestinal 5 (100.0) 5 (83.33) 
Skin rash/hives 3 (60.0) 5 (83.33) 
History of anaphylaxis 3 (60.0) 2 (33.33) 
Presence of Asthma, Hayfever, Eczema 5 (100.0) 6 (100.0) 
Medication Prescribed, n (%)   
Adrenalin auto-injector 3 (60.0) 2 (33.33) 
Antihistamines 6 (100.0) 6 (100.0) 
3.2. A CBT Model for Parents of Children with Food Allergy 
After initial assessments had been conducted, a longitudinal idiographic model was developed 
which described the experiences of the participants and was used in subsequent sessions to aid therapy 
(Figure 1). The model included issues prior to the diagnosis of food allergy that parents thought affected 
their present difficulties. Some were related to food allergy, such as problems in getting a diagnosis for 
their child, and some were not, such as mental health difficulties prior to having a child with food 
allergy. The model also included core beliefs described by the participants as related to their child’s 
food allergy, such as being a bad mother, being a failure as a parent and that the world is an unsafe place. 
Parents reported a number of dysfunctional assumptions they had developed, some examples of 
which can be seen in Figure 1. Activating events such as being invited to a party could trigger some or 
all of these dysfunctional assumptions and promote negative automatic thoughts which focused on 
risk, danger and inability of others to look after their child. A large list of emotions was generated by 
mothers, with some being more salient in particular situations. Anxiety was more predominant in situations 
such as being invited out to a social occasion or when trying a new food. Guilt was predominant when they 
had to ask someone else to look after their child or their child had an accidental reaction. 
These thoughts and feelings were associated with avoidance behaviours, such as not eating out, not 
going on holiday abroad or simply trying not to think about issues such as the possibility of their child 
having an anaphylactic reaction in the future. Mothers also exhibited safety behaviours such as constant 
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checking of their mobile phone when their child was not in their care. The physiology reported was 
similar to that exhibited in those suffering from anxiety or panic, such as increased heart rate; or was 
associated with low mood such as crying and fatigue. These thoughts, feelings, emotions and physiology 
then reinforced core beliefs and dysfunctional assumptions, thus maintaining the difficulties. 
Early Food Allergy Experiences
Child had an anaphylactic reaction when very 
young
Seeing child unwell and in distress due to 
symptoms
Took a long while to get a diagnosis of food 
allergy
Frustration with health care professionals
Formulation of dysfunctional assumptions:
If he goes out on his own he’s not in my control and if he 
has a reaction it will be my fault so I need to keep him with 
me; other people can’t be trusted to look after my son.  To 
keep my son safe I need to know everything I can about 
allergy and double check everything to make sure he never 
has a reaction by accident
Activating event/Critical incident
Invited to a party / accidental reaction to food
Activation of assumptions
Negative automatic thoughts:
The risk is too great, he could die
He’ll never have a normal life, it’s all my fault, have I 
checked the label properly?  Will they be able to look after 
my child? It’s too much effort, easier if he doesn’t go
Emotions:
Guilt; worry; anxiety; 
fear; scared; sadness; 
grief; frustration; low 
mood; irritable; anger
Core beliefs about self, others and the world
I am a bad mother; I can’t control others; the world is a 
dangerous place; I am a failure as a parent
Behaviour: check all 
labels many times; check 
mobile phone constantly 
when child at school; 
check child in the night; 
don’t go out to social 
occasions; don’t holiday 
abroad; don’t go back to 
work; remove allergenic 
food for all the family; try 
not to think about it all
Physiology:
Nausea, increased 
heart rate, headaches, 
crying, makes IBS 
worse, fatigue
Early Non Food Allergy Experiences
Traumatic experiences such as death 
of a child or spouse; always been a 
worrier; history of mental illness; bullied 
at school; single parent
At Diagnosis
Pre-Diagnoses
 
Figure 1. CBT model for food allergy. 
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3.3. Problems and Targets and Interventions Used 
Participants had between 3 and 4 problems each that they wished to address. Examples of these can 
be seen in Table 2. Each problem statement had a related end target and a range of evidence based 
CBT interventions were used to enable participants to achieve these. Examples of these can be seen in 
Table 3. For all participants psychoeducation about CBT, stress, anxiety, worry and depression was 
conducted. Education about food allergy was also delivered as confusion, misconceptions and erroneous 
beliefs were evident, particularly surrounding evidence for maternal diet causing allergy in their child, 
level of risk for child having a severe allergic reaction, how to use an adrenaline auto-injector (AAI), 
what skin prick tests showed and whether children can grow out of their allergies. 
Table 2. Examples of problem statements from participants. 
Problem Statements 
I feel very anxious and cry when I think about what might happen if my son has a serious reaction as I feel as if 
I won’t know what to do and he might die, so I try not to think about it or talk about it. 
I am very anxious when my son is not with me and I worry that he might eat something he shouldn’t and have a 
bad reaction, so I check my mobile every ten minutes in case I have missed a call about him, which makes me 
more anxious and I can’t concentrate on my work. 
I worry about how my daughter will cope as she gets older and more independent and wants to go out on her 
own with her friends. I am scared she won’t know what to do if she has a bad reaction so I find it hard to let her 
have some control over what she eats. 
I feel guilty asking other people to look after my daughter as they need to know what she can and cannot eat and 
how to give her an injection of adrenaline if she has a bad reaction, so most of the time I don’t let her go and 
stay with other people and that makes me feel guilty too. 
When we are going through a bad time with my daughter’s eczema I don’t get a lot of sleep and during the day I 
can feel really frustrated and angry and I shout at my daughter, which makes me feel guilty as she gets upset. 
I feel very anxious when we go out for the day as I have to do all the planning and work out what my son will be 
able to eat, I don’t get much help with this and I get frustrated and angry about that. 
Baseline and end of intervention mean ratings and the mean change scores for each participant for 
frequency of behaviour and for discomfort caused can be seen in Table 4. There was a significant 
reduction in problem statement ratings from baseline to end of treatment for frequency of behaviour  
(T = 0; z = −2.03, p = 0.042, r = 0.64) and for discomfort (T = 0, z = −2.03, p = 0.042, r = .64). There was 
also a significant reduction in target statement ratings from baseline to end of treatment for frequency 
of behaviour (T = 0, z = −2.02, p = 0.043, r = 0.64) and for discomfort (T = 0, z = −2.02, p = 0.043,  
r = 0.64). 
3.4. Impact of CBT on Quality of Life 
At baseline cases had significantly poorer physical and psychological QoL than controls (p = 0.05). 
They also had significantly worse food allergy specific QoL (p = 0.004) (See supplementary Table S1 
for the full data). At the end of the intervention there were no longer any significant differences 
between case and controls for QoL (all p > 0.05). 
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Participants in the CBT intervention group had significantly better physical QoL at the end of 
intervention compared to their baseline scores (p < 0.05). For all other generic areas of QoL the CBT 
group reported better QoL at the end of treatment but scores only approached significance. CBT 
participants had significantly less food allergy related parental burden at the end of the intervention  
(p < 0.05) (see supplementary Table S2). For controls there were no significant differences from 
baseline to the end of 12 weeks on any of these scale scores (all p > 0.05) showing that their QoL 
remained stable throughout the duration of the study (Supplementary Table S2).  
Table 3. Examples of end targets from participants with interventions utilised for each. 
Target Statements Interventions Used 
I would like to feel less anxious about  
my son having a bad reaction and be 
more confident in knowing what to do if 
he does 
1. Graded exposure to information about anaphylactic shock to 
reduce anxiety, including watching educational videos 
2. Psychoeducation about what might happen if a child goes into 
anaphylactic shock 
3. Role play using a trainer AAI with the parent and therapist 
4. Role play using a trainer AAI by the parent with their child 
I would like to worry less about my child 
becoming more independent as he gets 
older and trust him to take more 
responsibility for his allergies 
1. Worry tree to help decide what worries are controllable and what 
to do about them 
2. Behavioural experiment to see what happens if 
a. they allow child to read own food labels and decide what they 
can eat 
b. let child remember their medication and put their own creams on 
for their eczema 
3. Role play with child showing their friends how to use the trainer 
AAI in an emergency 
I would like to be able to leave my child 
with people and not feel guilty about this, 
so that I have more time for myself, and 
worry less when he’s not with me 
1. Psychoeducation and role play regarding how parent might teach 
someone else what they need to know about their child’s allergy 
and use of an AAI 
2. Behaviour experiment to test out consequences of leaving child 
with someone else 
3. Exploration of dysfunctional ways of thinking and making 
assumptions based on mind reading of others 
I would like to be able to learn how to 
cope with things when my child is having 
a bad time with her eczema and not feel 
angry, upset or low 
1. Diary to keep a log of mood 
2. Diary to log positive events and emotions in order to raise mood 
and self-esteem 
3. Challenging negative automatic thoughts such as “I cannot cope 
with this” and looking at evidence for and against such thoughts 
I would like to look back on the time 
when my daughter was tiny and very ill 
with her allergy and not get upset about it 
and remember the good times 
1. Emotional writing and re-living of past experiences to reduce 
grief associated with traumatic experiences 
2. Recording positive experiences from the past and the positive 
consequences that have occurred because of the food allergy, such 
as a better relationship with grandparents 
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Table 4. Mean problem and target baseline, end of treatment and change scores for  
each participant. 
Participant 
N of 
Problems 
Baseline End of Treatment Change Score 
  Behaviour Discomfort Behaviour Discomfort Behaviour Discomfort 
1 4 7.0 7.5 4.0 4.5 3.0 3.0 
2 4 5.5 6.25 1.5 2.25 4.0 4.0 
3 3 7.3 8.0 3.7 3.3 3.6 4.7 
4 3 6.0 8.0 2.0 2.0 4.0 6.0 
5 4 7.5 7.5 2.75 3.5 4.75 4.0 
Total  6.66 7.45 2.79 3.11 3.87 4.34 
 
N of 
Targets 
Baseline End of Treatment Change Score 
  Behaviour Discomfort Behaviour Discomfort Behaviour Discomfort 
1 4 8.0 8.0 2.0 2.0 6.0 6.0 
2 4 5.75 5.25 1.25 1.75 4.5 3.5 
3 3 7.0 7.0 4.3 3.7 2.7 3.3 
4 4 7.75 8.0 1.25 1.25 6.5 6.75 
5 4 7.75 7.75 2.75 3.25 4.75 4.5 
Total  7.25 7.20 2.31 2.39 4.89 4.81 
3.5. Impact of CBT on Psychological Distress 
At baseline the CBT group had significantly higher anxiety, depression and poorer general mental 
health (GHQ12 scores) than controls (all p < 0.05) (see supplementary Table S1). At the end of the 
intervention there were no longer any significant differences between cases and controls for anxiety 
and depression, however controls had significantly higher scores than cases on the GHQ12, demonstrating 
poorer mental health (p < 0.05) (see supplementary Table S1). 
Participants in the CBT intervention group had significantly less worry, anxiety and depression at 
the end of the intervention compared to their baseline scores. They also had significantly lower scores 
on the GHQ12 indicating better mental health (all p < 0.05). Reductions in levels of stress only approached 
significance (see supplementary Table S2). For controls, there were no significant differences from 
baseline to the end of 12 weeks on any of these scale scores, showing stability over time for these variables. 
At the start of the intervention four out of the five participants in the CBT group scored over the cut 
off levels for the GHQ12 and PSWQ and had moderate anxiety and three scored over the cut off for 
mild depression. Those scoring over the cut offs reduced over the course of the intervention, however 
numbers within each category were too small for analysis. (Full data can be seen in supplementary 
Table S3). 
4. Discussion 
This case series aimed to assess the appropriateness and effectiveness of Cognitive Behaviour Therapy 
for reducing psychological distress and improving quality of life in parents of children with food 
allergy. Mothers having CBT improved over time with significantly lower anxiety, depression and worry 
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and better QoL at the end of therapy compared to their baseline scores. CBT therefore seems to be 
appropriate for this group of people. 
4.1. A New CBT Model for Parents of Children with Food Allergy 
The CBT model developed after assessments with the mothers identified important issues not 
reported in the food allergy literature before. Factors unrelated to food allergy; such as previous mental 
health difficulties; past traumatic experiences and being bullied at school are often present in people 
suffering from mental illness such as depression; panic and generalised anxiety disorder [32] but have 
not been identified as possible risk factors for parental distress in those with a child with food allergy. 
Similarly core beliefs such as I am a bad mother; it is my fault my child has an allergy and others 
cannot be trusted to look after my child have not been conceptualised as core beliefs in the food allergy 
literature. Other beliefs; such as seeing the world as unsafe; overestimating the risk of death from food 
allergy; feeling that others have no understanding of the seriousness of allergy and its consequences 
and believing they are a bad mother for restricting their child’s social life have been reported before 
(e.g., [7,33,34]). Further investigation is required to understand how these negative beliefs are formed; 
particularly concerning the time at which they develop and why some parents of children with food 
allergy have such beliefs and others do not. It may be that negative core beliefs not related to food 
allergy are prominent before diagnosis and they become more salient over time in parents who find it 
hard to adjust and cope with their child’s allergies. Experiences regarding their inability to cope may 
then reinforce such beliefs. Early detection of negative core beliefs is therefore extremely important in 
identifying parents in need of support. 
Dysfunctional assumptions stemmed from mothers overestimating the risk of a serious reaction or 
death in their child and a need to keep their child safe. Although a level of vigilance is necessary and 
assessment of risk is a daily occurrence, participants in this study exhibited extreme levels of vigilance 
and avoidance. This could be due to previous experiences, particularly of anaphylaxis, increasing their 
fear, anxiety and uncertainty regarding the future health of their child. This level of vigilance can lead 
to more overprotective parenting styles [35], increase levels of anxiety [36] and prevent adaptive coping 
strategies from developing [33]. Negative automatic thoughts maintained these dysfunctional assumptions 
and triggered a range of emotions such as worry, anxiety, stress, fear, guilt, anger, sadness and grief. 
Anxiety and stress in particular have been identified in previous literature [4,9]. Anger, trauma and grief 
have only been reported very recently by parents who felt a loss of having a healthy child and the 
things they would not be able to do [33,37]. Experiences of an anaphylactic reaction in their child have 
been reported to have a lasting traumatic effect for the parent [6,37]. 
4.2. Psychological Outcomes for Parents of Food Allergic Children 
Anxiety reported by mothers in the CBT group in the present study was mainly around fears of their 
child having a serious reaction and worry about using the adrenaline auto-injector. Proussel et al. [38] 
found that parental knowledge for use of an AAI is quite poor and even though parents are shown how 
to use an AAI in clinic it may be many years before they need to actually use one if their child has well 
managed allergy. Recent research has found that many mothers quickly forget how to use their AAI 
after training provided at an allergy clinic [39]. Role play with a trainer AAI worked extremely well in 
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therapy in reducing anxiety and regular re-training in the use of AAIs would therefore be very useful, 
especially as parents who manage allergic reactions well can exhibit less distress [36]. Other anxieties 
were associated with letting others look after their child and their child becoming more independent as 
they grow older, which has been reported in the literature as an important issue to deal with [6,37]. 
Worry was very high in both the control and CBT groups, with many meeting criteria for Generalised 
Anxiety Disorder (GAD). GAD has not been reported in previous quantitative studies of food allergy, 
where measures of anxiety do not necessarily focus specifically on this type of worry. Worry has been 
reported by mothers taking part in qualitative studies; Springston et al. [34] conducted interviews with 
mothers who described being paralysed with fear and found their worries were constant and overwhelming. 
GAD in relation to food allergy warrants further investigation. 
Three out of the five mothers in the CBT group had mild depression and four scored over the cut-off 
for clinical caseness on the GHQ12. Few studies have measured depression in parents of children with 
food allergy but there is evidence that low mood is present in a small proportion of this population [9]. 
Grief and sorrow was also expressed regarding the loss of having a healthy child, which has only 
recently been identified in the literature [33]. 
In comparison to those in the CBT group, the majority of scores in the control group were low or in 
the normal range and scores generally remained stable across the 12 weeks, which is to be expected if 
they have developed and continue with adaptive coping strategies. Only a sub-set of parents of children 
with food allergy may therefore require referral to mental health treatment, a conclusion that has been 
reached by others [40]. Investigation of the type of parent able to cope compared to those who find it 
difficult would be beneficial in order to identify possible early interventions that could be put in place 
to help those parents who might go on to struggle once they have been given a food allergy diagnosis. 
From the present case series areas identified are: a history of mental illness, a tendency to worry about 
issues in other areas of their lives, misperceptions about the risk of a severe reaction, complex food 
allergies which take some time to diagnose or symptoms such as eczema which are difficult to control. 
It may also be a combination of these factors that is important. 
4.3. Quality of Life for Parents of Food Allergic Children 
Quality of life of parents in the CBT group significantly improved over time. CBT interventions 
aimed at increasing adaptive coping strategies and confidence in being able to cope with situations 
such as going on holiday and eating out therefore had a profound effect on reducing the burden felt by 
parents in these areas. 
Most areas of general QoL improved over time, possibly due to parallel improvements in stress, 
anxiety and depression and an increase in social activities. It is surprising that physical QoL improved 
in such a short period of time but may be due to improved sleep through a reduction in anxiety, stress 
and worries. 
4.4. Limitations of the Study and Areas for Further Research 
This study has a number of limitations. As this is a case series only a small number of participants 
are presented here and a larger sample is needed before preliminary findings from this study can be 
confirmed. Findings may be due to a response bias with participants who requested CBT being very 
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motivated to make changes. Small numbers meant that demographic differences between the intervention 
and control participants could not be ascertained and a fully randomised case control study needs to be 
run in order to ensure these factors are not related to the findings of the study. A study with a larger 
sample size would also enable analysis of differences regarding age of child, time since diagnosis of 
food allergy, effect of type of food and symptoms. The present study had a very narrow sample of white 
British females; CBT with fathers and participants of other socio-economic and ethnic backgrounds is 
needed, especially as these participants may have very different social and cultural expectations regarding 
their role in the family. It would also be beneficial to see if CBT is helpful in children themselves. 
The significant improvements in participants having CBT may be due to the therapeutic relationship 
rather than the CBT itself. A good therapeutic relationship is extremely important in producing successful 
outcomes for clients [41] and this may have produced improvements in cases in the present study, 
irrespective of the type of therapy they had. CBT interventions appeared to be extremely effective in 
the present study and could be targeted to specific difficulties discussed by mothers, lending some 
support to the argument that CBT is effective as a therapy. Studies utilising other therapies or merely 
providing someone for parents to talk to need to be compared with the efficacy of CBT in order to 
establish the best type of therapy for this client group. Efficacy of CBT was also only measured at the 
end of therapy, when a therapeutic relationship was still salient. Longer-term follow up is needed to 
ascertain lasting effects of CBT. 
It is possible that parents would have improved naturally over time without the aid of CBT, however, 
this is unlikely as not all CBT participants had children who were newly diagnosed and some had been 
struggling to cope for some time. Comparison with a wait-list control group who meet the criteria to 
have CBT is needed in order to confirm this. Finally it is not known whether pre-existing mental health 
difficulties caused parents to develop maladaptive coping strategies and exhibit increased levels of 
anxiety, worry and depression or whether it was caused by receiving a diagnosis of food allergy for 
their child. No participants had received therapy for mental health difficulties immediately preceding 
food allergy diagnosis and not all participants having CBT reported previous mental health difficulties, 
but this is certainly an area for further investigation with longitudinal research. 
4.5. Implications of the Results for Clinical Practice 
Parents who struggle to manage their child’s allergy and suffer high levels of distress need to be 
identified early and referred to mental health services when needed. Screening at allergy clinic may 
help identify those families at risk and results from the present case series offers some areas in which 
screening may be beneficial, including previous mental health difficulties, high levels of worry and 
anxiety, lack of social support and negative beliefs surrounding the allergy. Assumptions of risk and 
hyper-vigilance should also be assessed. 
CBT can be expensive, is not always available and there may be long waiting lists so ways in which 
aspects of CBT could be incorporated into routine clinical visits need to be developed and evaluated. 
The provision of good quality information about food allergy, which parents can use themselves and 
provide to their friends, family and child care providers is vitally important. Information about the possible 
psychological effects of food allergy on parents should be provided, including ways in which parents 
can develop adaptive coping strategies. The whole family should consider sharing of responsibilities of 
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food allergy to prevent high levels of burden on the mother. For those children that need adrenaline, 
AAI training should be given at clinic with repeater sessions at regular intervals and all parents should 
be provided with a trainer AAI to take home so that they and their children can practice. 
Provision of information about local and national support groups is important as normalising allergy 
and fostering an understanding that others have the same difficulties can help to reduce the stigma 
associated with food allergy and can help prevent parents feeling isolated [37]. Evaluation of the 
effectiveness of these strategies to reduce distress felt by parents and improve coping is needed. 
5. Conclusions 
Preliminary results from this case series show that CBT may be an effective therapy for parents of 
children with food allergy in reducing anxiety, worry, stress and depression and improving quality of 
life. Therapy needs to take into consideration the fact that anxiety may not be completely removed as 
this may in fact be detrimental to the child’s safety as it may reduce vigilance. Parents need to accept 
that their child will always live with risk and develop a balance between avoiding that risk and learning 
to live a relatively normal life [35]. CBT may be a therapy that can aid this learning, improve coping 
strategies used by parents and reduce the distress they feel. 
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